You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exatecan

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +3 more
  • (no location specified)
Jan 18, 2023

Advanced Solid Tumors Trial in Guangzhou (BAT8007 for injection)

Recruiting
  • Advanced Solid Tumors
  • BAT8007 for injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 26, 2023

Locally Advanced/Metastatic Solid Tumours Trial (BAT8009 for Injection)

Recruiting
  • Locally Advanced/Metastatic Solid Tumours
  • BAT8009 for Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 25, 2022

Advanced Solid Tumors Trial in Changchun (BAT8006 for Injection)

Recruiting
  • Advanced Solid Tumors
  • BAT8006 for Injection
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jul 26, 2022

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

Not yet recruiting
  • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 14, 2022

Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

Recruiting
  • Solid Tumor, Adult
  • +11 more
  • New Haven, Connecticut
  • +3 more
May 9, 2022

Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Trastuzumab-Deruxtecan (T-DXd)
  • (no location specified)
Sep 20, 2023

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

Solid Tumor Trial in Los Angeles, Fort Sam Houston, San Antonio (exatecan mesylate)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • exatecan mesylate
  • Los Angeles, California
  • +4 more
Jul 9, 2013

Lung Cancer Trial in Worldwide (exatecan mesylate)

Completed
  • Lung Cancer
  • exatecan mesylate
  • Helsinki, Finland
  • +5 more
Jul 9, 2013

Sarcoma Trial in Worldwide (exatecan mesylate)

Completed
  • Sarcoma
  • exatecan mesylate
  • Brussels, Belgium
  • +9 more
Jul 17, 2012

Sarcoma Trial in Canada, United States (exatecan mesylate)

Completed
  • Sarcoma
  • exatecan mesylate
  • Denver, Colorado
  • +8 more
May 15, 2012

Sarcoma Trial in Canada, United States (exatecan mesylate)

Completed
  • Sarcoma
  • exatecan mesylate
  • Denver, Colorado
  • +8 more
May 15, 2012

Esophageal Cancer, Gastric Cancer Trial in Canada, United States (exatecan mesylate)

Completed
  • Esophageal Cancer
  • Gastric Cancer
  • exatecan mesylate
  • Long Beach, California
  • +5 more
May 15, 2012

Breast Cancer Trial in Houston (exatecan mesylate)

Completed
  • Breast Cancer
  • exatecan mesylate
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
May 15, 2012

Prostate Cancer Trial in Houston, San Antonio (exatecan mesylate)

Completed
  • Prostate Cancer
  • exatecan mesylate
  • Houston, Texas
  • +1 more
May 15, 2012

Leukemia, MDS Trial in Houston (exatecan mesylate)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • exatecan mesylate
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
May 15, 2012

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial in Houston (exatecan mesylate)

Completed
  • Fallopian Tube Cancer
  • +2 more
  • exatecan mesylate
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
May 15, 2012

Pancreatic Cancer Trial in Baltimore, New York, San Antonio (exatecan mesylate)

Completed
  • Pancreatic Cancer
  • exatecan mesylate
  • Baltimore, Maryland
  • +2 more
May 15, 2012

Liver Cancer Trial in United States (exatecan mesylate)

Completed
  • Liver Cancer
  • exatecan mesylate
  • Denver, Colorado
  • +3 more
May 15, 2012

Brain and CNS Tumors, Lymphoma, Child Solid Tumor Trial in United States (filgrastim, exatecan mesylate)

Completed
  • Brain and Central Nervous System Tumors
  • +2 more
  • filgrastim
  • exatecan mesylate
  • New York, New York
  • +3 more
May 15, 2012

Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer Trial in United States (exatecan mesylate)

Completed
  • Extrahepatic Bile Duct Cancer
  • +2 more
  • exatecan mesylate
  • Denver, Colorado
  • +4 more
May 15, 2012

Cervical Cancer Trial in United States (exatecan mesylate)

Completed
  • Cervical Cancer
  • exatecan mesylate
  • Bronx, New York
  • +5 more
May 15, 2012

Pancreatic Cancer Trial in Canada, Puerto Rico, United States (exatecan mesylate, gemcitabine HCl)

Completed
  • Pancreatic Cancer
  • exatecan mesylate
  • gemcitabine hydrochloride
  • Huntsville, Alabama
  • +73 more
May 15, 2012